Smithers Avanza Adds Instrumentation To Newly Expanded Bioanalytical Laboratory, Increasing Capacity For Testing

GAITHERSBURG, Md.--(BUSINESS WIRE)--Smithers Avanza, a contract research organization (CRO) supporting the pharmaceutical industry, announced that it has added three additional instruments to its bioanalytical laboratory, following up on its recent building expansion; the Hamilton Microlab STAR pipetting workstation, the Meso Scale Discovery (MSD) MESO Sector S 600 plate reader and the Perkin Elmer EnSpire® multimode plate reader. These instruments, along with the recent additions to the physical lab space, increase Smithers Avanza’s capacity for bioanalytical testing.

“Growing in line with the needs of our clients is important as we seek to be the best and most reliable partner for independent, CLIA-certified and GLP-compliant testing related to the development of biologics,” said Ira DuBey, Executive Vice President, Bioanalytical Services Division, Smithers Avanza. “These new instruments will help our team to increase volume and efficiency of testing while also playing a role in ensuring timely delivery of study data.”

Smithers Avanza has broad and extensive experience in the development and validation of assays used for biotherapeutics development, including assays for pre-clinical applications and all phases of clinical development, Phase I through Phase IV. The CLIA-certified and GLP-compliant laboratory expanded recently, doubling in size to accommodate the increasing demand for bioanalytical services.

For more information about the Smithers Avanza portfolio of services and instrumentation, visit http://smithersavanza.com.

About Smithers Avanza

Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical industry. Our scientists have expertise in large molecule bioanalysis, assay development, validation, and specimen analysis at our GLP- and GCP-compliant and CLIA-certified laboratory. Smithers Avanza Bioanalytical Services Division supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays. The services focus primarily on development, validation, and specimen analysis for PK/TK, ADA, bioassays, and biomarker assays. Smithers Avanza also offers preclinical toxicology and vaccine testing at our AAALAC accredited facilities.